1. Most Discussed
  2. Gainers & Losers
NEU $1.19

Prof Brimble expects drug on market in a year or two

  1. boc1986

    1,571 Posts.

    An Auckland University scientist has discovered a drug to treat a crippling brain disease that affects thousands of women worldwide.
    Margaret Brimble and her team made the break-through that if approved will be the first New Zealand discovery registered by the United States Food and Drug Administration (FDA).
    Prof Brimble said the FDA might fast-track its registration so it could be sold in one or two years, as no drug is currently available for sufferers of Rett syndrome.
    Symptoms of the syndrome are similar to those of autism and cerebal palsy, and it affects about one in 12,000 girls. It also occasionally occurs in boys.
    Prof Brimble said trials had already proved it was safe and worked, giving hope to sufferers who generally only lived only to about 35 years of age.
    "It's a drug for a disease for which there is nothing for these patients," she said.
    "So anybody who had a daughter or a female member of their family who suffered Rett syndrome would spend their whole life just willing people to come up with a drug."

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.